We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

000568:SZSELuzhou Laojiao Co.,Ltd Analysis

Data as of 2026-07-29 - not real-time

CN¥88.23

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Luzhou Laojiao is trading at CNY 88.23, just below the short‑term resistance of CNY 89.5 and comfortably above the 20‑day SMA of 81.46, indicating some upside potential. The MACD histogram remains strongly positive (≈0.99) and the RSI sits at 60.6, suggesting momentum is still on the bullish side, while the 30‑day volatility is elevated at ~43% and the beta is low (≈0.32), reflecting a stock that can swing sharply but is relatively insulated from market moves. However, the price is still well under the 200‑day SMA of 108.89, and the broader trend is flagged as bearish, with a key support level near CNY 74.0. Fundamentally, the company boasts exceptional profitability – gross margin of 86.4% and operating margin of 60.2% – and generates robust cash flow (operating cash flow ≈ CNY 8.36 bn). The balance sheet is strong, with cash of CNY 31.4 bn against debt of CNY 6.69 bn, and the dividend yield of 6.84% is among the highest in the sector, supported by an 88% payout ratio. Yet the DCF‑derived fair value of CNY 57.6 is far below the current price, implying the stock is overvalued relative to intrinsic calculations, even as analysts project a median target of CNY 113 and maintain a “buy” consensus.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price near short‑term resistance
  • Bullish MACD but overall bearish trend
  • High dividend yield providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong profit margins and cash generation
  • Analyst price targets averaging above CNY 110
  • Defensive consumer‑staples positioning

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Heritage brand with stable demand for premium spirits
  • Sustainable dividend supported by free cash flow
  • Low beta and defensive sector reducing systematic risk

Key Metrics & Analysis

Financial Health

Revenue Growth-14.20%
Profit Margin40.76%
P/E Ratio13.1
ROE19.56%
ROA11.99%
Debt/Equity12.93
P/B Ratio2.5
Op. Cash FlowCN¥8.4B
Free Cash FlowCN¥4.7B

Technical Analysis

TrendBearish
RSI60.6
SupportCN¥74.03
ResistanceCN¥89.50
MA 20CN¥81.46
MA 50CN¥83.53
MA 200CN¥108.89
MACDBullish
VolumeIncreasing
Fear & Greed Index86.82

Valuation

Fair ValueCN¥57.57
Target PriceCN¥115.10
Upside/Downside30.45%
GradeOvervalued
TypeValue
Dividend Yield6.84%

Risk Assessment

Beta0.32
Volatility42.97%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.